B. Bui
-
- Sarcoma Diagnosis and Treatment 13
- Rheumatology top 10%
- Oncology top 10%
- Vascular Tumors and Angiosarcomas 6
- Pathology and Forensic Medicine top 10%
- Soft tissue tumors and treatment 3
- Neurology top 10%
- Neuroblastoma Research and Treatments 4
-
- Testicular diseases and treatments 4
- Vascular Malformations and Hemangiomas 2
-
- Cardiac tumors and thrombi 2
-
- Hematological disorders and diagnostics 2
B. Bui
21 papers receiving 612 citations
Peers
Comparison fields: 5 of 40
- Pulmonary and Respiratory Medicine 487
- Rheumatology 148
- Oncology 242
- Pathology and Forensic Medicine 154
- Neurology 96
Countries citing papers authored by B. Bui
This map shows the geographic impact of B. Bui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Bui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Bui more than expected).
Fields of papers citing papers by B. Bui
This network shows the impact of papers produced by B. Bui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Bui. The network helps show where B. Bui may publish in the future.
Co-authorship network
The 25 scholars most cited alongside B. Bui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 27 | |
| 2 | 2012 | 87 | |
| 3 | 2010 | 2 | |
| 4 | 2009 | 23 | |
| 5 | 2009 | 4 | |
| 6 | 2005 | 39 | |
| 7 | 2004 | 1 | |
| 8 | 2004 | 22 | |
| 9 | 2004 | 2 | |
| 10 | 2003 | 104 | |
| 11 | 2002 | 24 | |
| 12 | 2001 | 150 | |
| 13 | 2000 | 1 | |
| 14 | [Case report forum: the example of French sarcoma group multidisciplinary discussion tools. Sarcomes de la FNCLCC]. | 2000 | 0 |
| 15 | 1999 | 2 | |
| 16 | 1999 | 5 | |
| 17 | 1998 | 31 | |
| 18 | 1998 | 2 | |
| 19 | Phase II study of epirubicin in advanced soft tissue sarcoma. | 1990 | 14 |
| 20 | 1985 | 85 |
About B. Bui
B. Bui is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Neurology, Rheumatology and Pathology and Forensic Medicine, having authored 22 papers that have together received 637 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (13 papers), Vascular Tumors and Angiosarcomas (6 papers), Testicular diseases and treatments (4 papers), Neuroblastoma Research and Treatments (4 papers), Soft tissue tumors and treatment (3 papers), Cardiac tumors and thrombi (2 papers), Vascular Malformations and Hemangiomas (2 papers) and Hematological disorders and diagnostics (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (487 citations), Rheumatology (148 citations), Oncology (242 citations), Pathology and Forensic Medicine (154 citations) and Neurology (96 citations). B. Bui has collaborated with scholars based in France, Luxembourg and Italy. Frequent co-authors include Philippe Terrier, Odile Oberlin, Marie‐Cécile Le Deley, Jean Michon, Jean‐Claude Gentet, Thierry Philip, Claudine Schmitt, Françoise Méchinaud, C. Carrié and Jean‐Michel Coindre. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Melanoma Research, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.